Literature DB >> 17037550

Avian infectious bronchitis virus enters cells via the endocytic pathway.

Victor C Chu1, Lisa J McElroy, A Damon Ferguson, Beverley E Bauman, Gary R Whittaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037550      PMCID： PMC7123215          DOI： 10.1007/978-0-387-33012-9_54

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  16 in total

Review 1.  How viruses enter animal cells.

Authors:  Alicia E Smith; Ari Helenius
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

2.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Influenza virus entry and infection require host cell N-linked glycoprotein.

Authors:  Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

5.  Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Production and characterization of monoclonal antibodies to three infectious bronchitis virus serotypes.

Authors:  K Karaca; S Naqi; J Gelb
Journal:  Avian Dis       Date:  1992 Oct-Dec       Impact factor: 1.577

7.  Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.

Authors:  Jedrzej Małecki; Antoni Wiedłocha; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

8.  An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids.

Authors:  L V Chernomordik; E Leikina; V Frolov; P Bronk; J Zimmerberg
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

9.  Electron microscope observations on the entry of avian infectious bronchitis virus into susceptible cells.

Authors:  S Patterson; R W Bingham
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Coronavirus IBV-induced membrane fusion occurs at near-neutral pH.

Authors:  D Li; D Cavanagh
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574
View more
  4 in total

1.  Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Authors:  Adriaan H de Wilde; Dirk Jochmans; Clara C Posthuma; Jessika C Zevenhoven-Dobbe; Stefan van Nieuwkoop; Theo M Bestebroer; Bernadette G van den Hoogen; Johan Neyts; Eric J Snijder
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

Review 2.  Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.

Authors:  Jimin Xu; Yu Xue; Richard Zhou; Pei-Yong Shi; Hongmin Li; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-05       Impact factor: 12.944

Review 3.  Repurposing host-based therapeutics to control coronavirus and influenza virus.

Authors:  Cui-Cui Li; Xiao-Jia Wang; Hwa-Chain Robert Wang
Journal:  Drug Discov Today       Date:  2019-01-31       Impact factor: 7.851

4.  Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.

Authors:  Marion Plaze; David Attali; Matthieu Prot; Anne-Cécile Petit; Michael Blatzer; Fabien Vinckier; Laurine Levillayer; Jeanne Chiaravalli; Florent Perin-Dureau; Arnaud Cachia; Gérard Friedlander; Fabrice Chrétien; Etienne Simon-Loriere; Raphaël Gaillard
Journal:  Int J Antimicrob Agents       Date:  2020-12-30       Impact factor: 5.283
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.